8 December 2025
By Roger Kennedy
roger@TheCork.ie
Primecore — the life-sciences consultancy now stepping up its global operations — has announced plans to create 100 new positions over the next three years. The move marks a clear push in its international growth strategy. A significant portion of these specialist roles is expected to land in Ireland, as the company deepens its presence in key pharma-tech hubs.
As Primecore expands its capabilities in advanced pharma-tech, adjustments are emerging across other industries as technology continues to reshape how services are delivered. Similar demands for precision and dependable systems now shape automated logistics, advanced manufacturing and cloud-based quality controls — all areas where structured processes mirror those found in Primecore’s work. The same pattern is evident across the online world and entertainment too, where platforms increasingly rely on standardised features and predictable user functions, from streaming services to competitive gaming hubs and other interactive digital formats.
For example, online casinos now offer a broad mix of classic and modern slot titles, each with their own style of play and varying levels of volatility. Payment options have widened too, with both traditional methods and newer digital systems giving users more flexibility in how they manage transactions. The growing interest in UK online slots for real money is often linked to steady improvements in fairness, transparent RTP information and the overall reliability of the technology behind these services.
These developments across digital services show how wider technological progress is setting new expectations for clarity and dependable performance, whether in regulated entertainment or in highly specialised technical fields. It’s a reminder that industries built on structured systems tend to evolve along similar lines, with each shift in capability creating fresh demands for skilled people who can manage increasingly complex processes. That broader context sits in the background as Primecore outlines its next phase of growth in Ireland.
According to the company’s latest announcement, roughly one-third of the new roles will be based in Ireland, supporting the existing offices in Cork and Dublin. The expansion comes on the back of a recent change in ownership and the arrival of a new leadership team at Primecore.
The company’s new direction follows a broader review aimed at strengthening its delivery capacity in regions where demand for specialist pharma-tech support continues to grow. Primecore says Ireland’s strong life-sciences base — along with its concentration of advanced manufacturing and biopharma expertise — makes it a natural choice for expanding project activity. The decision to build out the Cork operation reflects both the scale of upcoming programmes and the need for specialist talent capable of managing complex, technology-driven initiatives.
Primecore works across operations consultancy for the biopharmaceutical sector, covering product and pipeline programme management, manufacturing support, supply-chain design, capital project delivery and operational services for biotech and gene-therapy firms. As demand rises for advanced technology and technical expertise within the life-sciences arena, the company aims to grow its team with experienced project managers, seasoned consultants and senior technical specialists.
The company’s plans set a high bar. Primecore’s annual revenue currently sits at around US $12 million, with a target of more than doubling that figure to US $30 million by 2028. While the majority of its revenue at present comes from the United States, the move to strengthen its Irish operations signals confidence in the growth potential of Europe’s life-sciences sector.
Recruitment has already begun, with the company seeking professionals in capital project delivery, supply-chain strategy and consultancy for high-stakes biopharma programmes. The expansion is seen as a vote of confidence in Cork’s ability to support high-tech life-sciences roles, underscoring the city’s growing position in the global pharmaceutical and biotech supply chain.